Alterola Biotech Inc
OTC:ABTI
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Alterola Biotech Inc
OTC:ABTI
|
7.5m USD |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
212.9B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
112.9B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.6T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
35.7B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
42.9B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
22.7B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
2.9T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
894.4B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
Other Profitability Ratios
Alterola Biotech Inc
Glance View
Alterola Biotech, Inc. develops medical cannabis products. The company is headquartered in Walnut, California. The company went IPO on 2010-03-09. The firm is focused on developing pharmaceutical medicines made from cannabinoid, cannabinoid-like and non-cannabinoid active pharmaceutical ingredients (APIs) globally. The company is also focused on developing non-pharmaceutical (nutraceutical / dietary supplement) products containing cannabinoids, cannabinoid-like and non-cannabinoid food-grade ingredients. In addition, the Company is focused on supplying cosmetic ingredients to potential customers who develops products containing cannabinoids, cannabinoid-like and non-cannabinoid ingredients.
